Cuu Long Pharmaceutical JSC (HOSE:DCL)

HOSE:DCL Revenue

Cuu Long Pharmaceutical JSC had revenue of 324.12B VND in the quarter ending March 31, 2026, a decrease of -4.67%. This brings the company's revenue in the last twelve months to 1.31T, down -4.62% year-over-year. In the year 2025, Cuu Long Pharmaceutical JSC had annual revenue of 1.32T with 1.13% growth.

• Revenue (ttm): 1.31T
• Revenue Growth: -4.62%
• P/S Ratio: 2.18
• Revenue / Employee: 1.47B
• Employees: 891
• Market Cap: 2.85T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.32T	14.79B	1.13%
Dec 31, 2024	1.31T	162.85B	14.24%
Dec 31, 2023	1.14T	128.26B	12.63%
Dec 31, 2022	1.02T	312.05B	44.35%
Dec 31, 2021	703.63B	32.39B	4.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error